Randomized, Multicenter, Double Blind Study to Compare the Efficacy and Tolerability of Oleogel-S-10 for 3 Month Versus Placebo Only in Patients With Mild to Moderate Actinic Keratoses Located at the Face and Head Oleogel-S-10 in Actinic Keratoses Trial.

Trial Profile

Randomized, Multicenter, Double Blind Study to Compare the Efficacy and Tolerability of Oleogel-S-10 for 3 Month Versus Placebo Only in Patients With Mild to Moderate Actinic Keratoses Located at the Face and Head Oleogel-S-10 in Actinic Keratoses Trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Aug 2015

At a glance

  • Drugs Oleogel S10 (Primary)
  • Indications Actinic keratosis; Skin cancer
  • Focus Therapeutic Use
  • Acronyms BETA-Trial
  • Sponsors Birken AG
  • Most Recent Events

    • 26 Oct 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2008-002632-15).
    • 09 May 2012 New source identified and integrated (German Clinical Trials Register; DRKS00003616).
    • 28 Jan 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top